Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-04

FDA Approved: VEMLIDY — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Vemlidy (tenofovir alafenamide) from Gilead Sciences; the action represents a regulatory update to the product. This…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vemlidy (tenofovir alafenamide)

Snippet

SUPPL AP for VEMLIDY (TENOFOVIR ALAFENAMIDE)